Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
GM-CSF: A Target for Brain Inflammation Intervention in MS?
Sustained low rate of brain volume loss under long-term fingolimod treatment in relapsing multiple sclerosis: results from the LONGTERMS study
Nature, Nurture, and What’s in Between
RTL1000
Episode 91 with Dr. Jorge Nogales-Gaete on MS patients' perceptions and needs
Papers: 21 Mar 2016 - 28 Mar 2016
Gut Bacteria Boost Anti-Inflammatory Immune Cells in Mice
“Long Life” Protein Klotho Powers Remyelination in Mice
New Funding Opportunities: Challenge Awards and Infrastructure Awards Deadline - January 31, 2014
Vitamin D3 Blocks T Helper Cells From Entering the CNS
International Progressive MS Alliance Announces New Research Grants
rhGH effect on remyelination
Imilecleucel-T
Transdermal Myelin Peptides May Be Safe, Effective in MS
MS Patient, Ph.D.: Greetings From Limbo Land
Episode 89 with Dr. Charity Evans on the effect of beta-interferon on hospital event rates
Explaining Fingolimod’s Fatal Flaw
Dorsiflexion Assist Orthosis Helps MSers Walk
Amiloride
MS Research Roundup: March 2, 2015
Stopping Natalizumab May Increase Risk of MS Relapse
2 exciting Science papers say Alzheimer's amyloid had MS mice walking
NMDA Receptors May Modulate Severity of Multiple Sclerosis
Antigen-Specific Therapy for MS Passes Safety Test
MS Research Roundup: 8 January 2016
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »
